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Available online 27 February 2016A newly-described ﬁrst-line immune defencemechanism of neutrophils is the release of neutrophil extracellular
traps (NETs). Immune complexes (ICxs) induce low level NET release. As such, the in vitro quantiﬁcation of NETs
is challenging with current methodologies. In order to investigate the role of NET release in ICx-mediated auto-
immune diseases, we developed a highly sensitive and automatedmethod for quantiﬁcation of NETs. After label-
ling human neutrophils with PKH26 and extracellular DNA with Sytox green, cells are ﬁxed and automatically
imaged with 3-dimensional confocal laser scanning microscopy (3D-CLSM). NET release is then quantiﬁed
with digital image analysis whereby the NET amount (Sytox green area) is corrected for the number of imaged
neutrophils (PKH26 area). A high sensitivity of the assay is achieved by a) signiﬁcantly augmenting the area of
the well imaged (11%) as compared to conventional assays (0.5%) and b) using a 3D imaging technique for opti-
mal capture of NETs,which are topologically superimposed on neutrophils. In this assay, we conﬁrmed low levels
of NET release upon human ICx stimulation which were positive for citrullinated histones and neutrophil elas-
tase. In contrast to PMA-induced NET release, ICx-induced NET release was unchanged when co-incubated
with diphenyleneiodonium (DPI). We were able to quantify NET release upon stimulation with serum from RA
and SLE patients, which was not observed with normal human serum. To our knowledge, this is the ﬁrst semi-
automated assay capable of sensitive detection and quantiﬁcation of NET release at a low threshold by using
3D CLSM. The assay is applicable in a high-throughput manner and allows the in vitro analysis of NET release
in ICx-mediated autoimmune diseases.
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Neutrophil extracellular traps (NETs) are extracellular strands of
DNA that are expulsed upon the interaction of neutrophils with infec-
tious pathogens such as Staphylococcus aureus [1], Salmonella typhi, Shi-
gella ﬂexneri [2], Candida albicans [3] and Aspergillus fumigatus [4]. The
extracellular NET ﬁbres were demonstrated to be composed of nuclear
chromatin, citrullinated histones and multiple granular antimicrobial
and cytoplasmic proteins like myeloperoxidase (MPO) and neutrophil
elastase (NE) [2]. The physiological function of NETs is the entrapment
and subsequent elimination of these pathogens. NETs are therefore con-
sidered as part of a ﬁrst line defence mechanism and, as such, the anti-
microbial armamentarium of neutrophils consists of phagocytosis,
degranulation of lysozymes and extrusion of NETs.
The discovery of NETs as a source of extracellular DNA has triggered
several investigations to study its role in autoimmune diseases (AIDs),
because extracellular DNA is an established trigger of autoimmunity
[5]. NETs are postulated to have a potentially pathogenic role in
ANCA-associated small-vessel vasculitis [6,7], systemic lupus erythema-
tosus [8,9] and rheumatoid arthritis [10]. Moreover, reduced degrada-
tion of NETs was associated with more severe disease in AID patients
[11,12]. Because almost any pathogen can induce NET formation, it
seems unlikely that in light of the many (subclinical) microbial attacks
that humans continuously face, every ‘infection’ also potentially induces
an autoimmune response. Therefore, it is relevant to identify non-
infectious triggers of NET formation which contribute to increased
NETosis as underpinning pathogenic mechanisms of autoimmunity.
To address the issue of NET-inducing triggers, current studies are
hampered by the lack of a reliable and sensitive quantiﬁcation method
of NET formation. In contrast to PMA-induced NETosis which usually
leads to an overwhelming extrusion of DNA, physiological stimuli like
immune complexes (ICxs)) induce more subtle and lower levels of
NET formation [13]. Currently, two methods are commonly used to
quantify NET release in vitro: DNA measurements in supernatant [7,8,
14] or demonstration of extracellular DNA by immunocytochemistry
[6,15–17]. With respect to the ﬁrst method, DNA measurements are
straightforward and objective but not speciﬁc for NETs. Also, several
molecules, most importantly immunoglobulins, can interfere with ﬂuo-
rescencemeasurements [18].With respect to the secondmethod, quan-
tiﬁcation based on immunocytochemistry is heterogeneously reported
by number of netting neutrophils, neutrophils with decondensed nuclei
or area of extracellular DNA after image analysis. This method is prone
to subjectivity of the observer and is quite labour intensive. Therefore,
the aim of the present studywas to develop a highly sensitive, objective
and reproducible NET quantiﬁcation assay applicable in a high-
throughput system. Here, we describe how ICx-induced NET formation
is sensitively detected and quantiﬁed by a semi-automated, confocal
laser scanning microscopy (CLSM) 3D-imaging technique.
2. Methods
2.1. Patient samples
All serum samples were obtained after informed consent. Peripheral
blood was obtained without anticoagulants and serum samples were
stored at−80 until use. Twenty-seven rheumatoid arthritis (RA) and
20 systemic lupus erythematosus (SLE) serum samples were collected.Six normal human serum (NHS) samples, acquired from a healthy
donor bank, were used as a control. 10% serum was used in the assay
and each sample was tested in triplicate within one experiment.
2.2. Preparation of neutrophils
Twenty millilitres of whole blood was collected in EDTA-coated
tubes. Neutrophils were isolated by density gradient centrifugation
with Ficoll-amidotrizoaat (LUMC, Leiden, The Netherlands) followed
by erythrocyte lysis. Cells were counted using trypan blue, labelled
with PKH26 (2 μM, Sigma-Aldrich, Saint-Louis, MO, USA) and then
3.75 × 104 neutrophils were seeded per well into a 96-well culture
plate in a phenol red-free RPMI 1640 medium (Life Technologies, The
Netherlands) supplemented with 2% heat-inactivated foetal calf serum
(FCS). Neutrophils were stimulated during 3:45 h with any given stim-
ulus. Stimuli used weremedium (negative control), intravenous immu-
noglobulins (IVIG) (Nanogam 50 mg/mL; Sanquin, Amsterdam, The
Netherlands), puriﬁed IgG, heat-aggregated IgG immune complexes or
phorbol myristate acetate (PMA) (Sigma-Aldrich). For NADPH oxidase
inhibition, 1 μM diphenyleneiodonium (DPI) (Sigma-Aldrich) was
used. Hereafter, an impermeable DNA dye, 1 μM Sytox green (Life
Technologies), was added for 15 min after which neutrophils were
ﬁxed with 4% formaldehyde (Added Pharma).
2.3. Fluorescence immunocytochemistry of NETs
PKH-labelled neutrophils were seeded onto poly-D-lysine-coated
coverslips (Corning, NY, USA) and NETs were induced according to the
abovementioned protocol. Fixed neutrophils were blocked with 1%
BSA and 5% normal goat serum in PBS and stainedwith polyclonal rabbit
anti-human citrullinated histon3 (10 μg/ml, Abcam) or a mouse mono-
clonal anti-human citrullinated histon3 (10 μg/ml, Abcam) and poly-
clonal rabbit neutrophil elastase (NE) (10 μg/ml, Abcam) in PBS and
incubated for 2 h. Then, neutrophils were washed and incubated with
a 1/500 dilution secondary goat anti-rabbit Alexa488 antibody (Life
Technologies) or with a 1/500 dilution secondary goat anti-mouse
Alexa488 antibody (Life Technologies). The secondary antibodies were
pre-incubated for 30 min with 10% normal human serum to bind anti-
human immunoglobulins. After 60 min incubation, neutrophils were
washed and stained with Hoechst 33258 (1 μg/ml, Life Technologies).
Images were acquired with the Leica DMI6000 inverted microscope
using a 20× magniﬁcation.
2.4. Preparation of heat-aggregated IgG immune complexes
IgG was enriched from pooled healthy human sera by the use of a
diethylaminoethyl (DEAE) cellulose anion exchange column (GE
Healthcare) [19]. Samples were centrifuged over the DEAE column and
subsequently the column was ﬂushed with TRIS buffer. The eluate con-
taining IgG was concentrated with a centrifugal ﬁlter unit with a cut-off
at 30 kDa (Merck Millipore). IgG enrichment was conﬁrmed with SDS-
polyacrylamide gel electrophoresis (10% Mini-Protean TGX gel, Biorad).
Brieﬂy, the precast gel was run with non-reduced and reduced samples
(reducing agent DTT, New England Biolabd) at 30mA at room tempera-
ture. Bandswere detectedwith Coomassie Brilliant Blue protein staining
(Biorad). The obtained IgGwas aggregated by heating in a water bath at
63° for 20 min at a concentration of 25 mg/ml. Then, the solution was
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aggregates, was loaded on a Sepharose 4B column (GE Healthcare) for
fractionation of the IgG aggregates. A solution of monomeric IgG was
used as a standard. Large aggregates, consisting of more than 40 IgG
monomers, were collected to use in the confocal laser scanning micros-
copy (CLSM) NET assay. Monomeric IgG was used as a control. The IgG
concentration was deﬁned with a Pierce assay.
2.5. Visualization of neutrophil extracellular traps
Immediately following ﬁxation, neutrophil extracellular traps
(NETs) were visualized by confocal laser scanning microscopy (CLSM)
using the automated BD Pathway 855 (BD Biosciences, San Jose, CA,
USA). Brieﬂy, 12 z-stacked images of 25 predeﬁned high power ﬁelds
(HPFs) at a 20× magniﬁcation were captured. The HPFs were evenly
spread throughout the well by a standardized 5 × 5 zig-zag pattern
with 400 μm (length) and 500 μm (width) spaced between each high
HPF.
The well area covered by the above-described microscopic imaging
was calculated as follows: 1) the area of a HPF at a 20× magniﬁcation
was calculated at 3.3 ∗ 106 μm2 (length 417.39 μm × width 318.01 μm);
2) the area of a HPF at a 40× magniﬁcation was calculated at
0.8 ∗ 106 μm2 (length 210.49 μm × width 160.38 μm); 3) total area
covered was calculated by multiplying the number of HPFs by the HPF-
area at a givenmagniﬁcation. The microscope was programmed to auto-
matically focus on PKH26 membrane staining. Then, for each image
PKH26 (Cy3) and Sytox green (alexa488) were visualized. The CLSM ex-
posure time for Sytox green was set on the positive control and for
PKH26 on the negative control. The same exposure time was applied to
all images in the same experiment.
2.6. Automatic digital image analysis for the quantiﬁcation of
NET formation
Acquired images were automatically analysed by ImageJ image
analysis software (NIH, Bethesda, MD, USA). Extracellular DNA of
NETs was quantiﬁed as the cumulative area of positive Sytox green.
To correct for the number of neutrophils, the mean area of positive
PKH26 staining was quantiﬁed. Thus, the ratio of both areas is calcu-
lated, representing the NET area corrected for the amount of imaged
neutrophils in each sample. A higher ratio indicates a larger NET area
present.
3. Results
3.1. NETs are induced at lower levels by human immune complexes as
compared to PMA
Immune complexes are considered as pathogenic compounds in
human autoimmune diseases and capable of inducing NETs [20,21].
We ﬁrst conﬁrmed that human heat-aggregated IgG ICx indeed induced
NET formation. Extracellular DNAwas detected by immunoﬂuorescence
and we conﬁrmed that the extracellular DNA was positive for
citrullinated histones (citH3) and neutrophil elastase (NE) (Fig. 1A, B).
Visually, ICx induced NET release at much lower levels compared to
PMA (Fig. 1C). We were unable to pick up low levels of ICx-induced
NET release compared to medium control, which was indeed the case
for PMA-induced NET release (Fig. 1D). Of note, similar results were ob-
tained when using Picogreen and Sytox green ﬂuorescence measure-
ments on supernatants of these conditions (data not shown). In-depth
exploration to improve visualization of NETs, we noted that NETs
were topologically superimposed on the neutrophils: Fig. 1E illustrates
that by using stacked imaging, neutrophils were found attached to the
bottom of a well while released NETs were predominantly observed
on top of the neutrophils. Comparing NET quantiﬁcation, we demon-
strated a signiﬁcant higher result for ICx-induced NET release in three-dimensional (3D) imaging (mean NET area ± SEM: 1.03 ± 0.11) as
compared to 2D imaging (mean NET area ± SEM: 0.04 ± 0.01, p =
0.01) (Fig. 1F). Altogether, sensitivity to quantify low levels of NETs
upon ICx stimulation was increased by visualizing NET release
3-dimensionally (3D).
3.2. Automatization of 3D CSLM image acquisition
Because ICx induced NETs in fewer neutrophils as compared to PMA,
we aimed to further augment the sensitivity of the NET quantiﬁcation
assay by increasing the total imaged surface to yield a higher number
of neutrophils. By varying the fully automated image acquisition tech-
nique we showed that increasing number of HPFs and reducing the
magniﬁcation led to larger image areas, correlating with a 10-fold in-
crease of imaged neutrophils (Fig. 2A, B). When the 40× magniﬁcation
was used, the area of the well captured is 2.8% when 25 HPFs were im-
aged, representing 194 ± 66 neutrophils (mean ± SEM). For optimal
acquisition, 11.1% area of thewell was capturedwhen 25HPFswere im-
aged with the 20× magniﬁcation, thereby analysing 1500 ± 247 neu-
trophils (mean ± SEM). We conﬁrmed that imaging a larger well area
by increasing the number of HPFs, resulted in a higher yield of neutro-
phils (Fig. 2C). To exclude observer subjectivity, 25 HPFs were captured
in a constant pattern throughout eachwell, as illustrated in Fig. 2D. Cap-
tured images from 25HPFswere stitched together to form onemontage
and 12 montages per well were mounted to form a 3D-image, which
was used for digital image analysis (Fig. 2E and Supplemental movie).
When performing image analysis, the amount of NET release is calcu-
lated by the total area of Sytox green (%), corrected for the amount of
imaged cells calculated by the total area of PKH26 (%). The NET area
per amount of imaged neutrophil is thus calculated by the total area
of NETs (Sytox positive) divided by the amount of neutrophils, rep-
resented by the mean area of PKH26. Regardless of the induction of
NETosis, we demonstrated that the total area of PKH26 (%) correlat-
ed signiﬁcantly with neutrophil counts in unstimulated conditions
(r = 0.99, p b 0.0001) and ICx-stimulated conditions (r = 0.95,
p b 0.0001) (Fig. 2F, G). PKH staining is drastically decreased upon
PMA stimulation (75% with 12.5 nM PMA) compared to ICx stimula-
tion (34% with 12.5 μg/ml ICx) (Fig. 2H, I), suggesting increased neu-
trophil death and/or cell loss with PMA compared to ICx-induced
NETosis.
3.3. High sensitivity quantiﬁcation of ICx-induced NET release shows a
ROS-independent process
Using the above-described high-sensitivity NET quantiﬁcation assay,
we conﬁrmed its applicability by further investigating ICx-induced NET
release (see Fig. 3). Low levels of ICx induced NET release (mean NET
area per neutrophil ± SEM: 1.1 ± 0.5) were not signiﬁcantly different
when diphenyleneiodonium (DPI) was added (mean NET area per neu-
trophil ± SEM: 0.8 ± 0.2, p N 0.05). PMA induced large amounts of NET
release (mean NET area per neutrophil ± SEM: 107 ± 5.8) which was
almost completely inhibited by DPI (mean NET area per neutrophil ±
SEM: 2.9±0.0, p b 0.005). Fig. 3B conﬁrmed these ﬁndings in cross-sec-
tional overviews of 3-dimensional images of each condition with and
without DPI. Overall, these ﬁndings indicate that human ICx induce
NETs in a ROS-independent manner.
3.4. RA and SLE serum samples show NET-inducing capability compared to
normal human serum
To further conﬁrm applicability of this assay in the analysis of NET
release in ICx-mediated autoimmune diseases, we next used this
assay to quantify NET release induced by serum of patients with
rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
The mean NET area ± SEM per imaged neutrophil upon induction
with RA serum was 0.46 ± 0.08, 0.69 ± 0.18 for SLE and 0.12 ±
580 T. Kraaij et al. / Autoimmunity Reviews 15 (2016) 577–5840.06 for the NHS control (Fig. 4A). For RA, 18 out of 27 serum samples
(67%) showed increased NET-inducing capacity compared to the
NHS control and in SLE, 17 out of 20 samples (85%) showed increased
NET-inducing capacity (Fig. 4B).4. Discussion
Thepresent study describes a novelmethod for automatic andhighly
sensitive quantiﬁcation of NET release based on CLSM. With this assay,
Fig. 2. Automatization of 3D CSLM image acquisition. The yield of (potentially netting) neutrophils is augmented by increasing the area per well imaged. (A) At a 40× magniﬁcation, 3D
CSLM is capable of automatically imagingup to 2.8% of eachwell area. (B) At a 20×magniﬁcation, 3DCSLM is capable of automatically imagingup to 11.1%of eachwell area. (C)Depicted is
the total amount of imaged neutrophils correlated to the imaged well area. Mean ± SEM are shown. (D) Thus, optimal yield was achieved by automatically capturing a ﬁxed pattern 25
high power ﬁelds (HPFs) images for eachwell. (E) For image analysis, 25 HPF images aremerged to onemontage resulting in a total of 12montages for eachwell suitable for digital image
analysis. (F) When capturing high numbers of neutrophils, the percentage area of PKH26 correlates signiﬁcantly with the amount of imaged neutrophils (unstimulated). (G) This
correlation is preserved even after ICx-induced NET release (ICx 12.5 μg/ml). Seventy-two montages were analysed. (H, I) Relative in vitro neutrophil cell loss after ICx-induced NET
release is lower compared to PMA-inducedNETosis. The amount of neutrophilwas quantiﬁed by percentage area of PKH26 positivity. Depicted is the relative reduction in percentage area.
581T. Kraaij et al. / Autoimmunity Reviews 15 (2016) 577–584we were able to demonstrate that the NET release upon stimulation
with human heat-aggregated IgG immune complexes is independent
of ROS production. Moreover, we show the applicability of this assay
to quantify NET-inducing capacity in sera from RA and SLE patients.
The hallmark of the current method is its high sensitivity, which is
based on two novel assay features. First, we introduced for the ﬁrst
time 3D imaging in a NET quantiﬁcation assay. Since we observed that
NETs are superimposed on neutrophils, we developed a more reliable
detection of NETs by obtaining 12 z-stack images. Thus, we were able
to demonstrate that low levels of NET release could be detected with
3D but not with 2D imaging. Second, the acquisition of (potentiallyFig. 1. Human immune complexes (ICx) induce low level NET release detectable with three-di
extracellular DNA detected by Hoechst (blue) which are positive for the NET-speciﬁc marker c
(NE — green). Staining is representative of 3 separate experiments. (C) The amount of NET
neutrophils were stimulated for 4 h with either 12.5 μg/ml ICx or 12.5 nM PMA and NETs w
taken along as controls. Subsequently, a montage image consisting of 25 high power ﬁelds (H
NET release induced by ICx is not detected when quantiﬁed with the % area of positive Sy
demonstrated that NETs (green) are topologically superimposed on neutrophils (red). (F) Qua
yields signiﬁcantlymoreNETs as compared to a single focus 2D image (p b 0.05 for ICx 12.5 μg/mnetting) neutrophils is increased by imaging 11% of the total well area.
In comparison, conventional methods based on ﬂuorescence microsco-
py quantify 5–10 HPFs at 40× magniﬁcation correlating with an image
area of 0.5–1% of eachwell [22,23]. The automated quantiﬁcationmeth-
od developed by Brinkmann obtained 5% of each well area by capturing
5 images randomly spread throughout the well with a 10× magniﬁca-
tion [16]. When increasing the imaged area, we also show that an in-
creased number of neutrophils is captured. Because the amount of
measured NET release is directly related to the number of neutrophils
captured in each HPF, we validated that PKH26 matched with the
large number of neutrophils imaged. Of note, it is important to realizemensional CSLM. (A) PKH26-positive (red) neutrophils incubated with human ICx release
itrullinated histon3 (citH3 — green) and, (B) the NET-speciﬁc marker neutrophil elastase
release is visually lower compared to PMA-stimulated NET release. PKH-labelled (red)
ere stained with Sytox (green). Medium and the corresponding IgG concentration were
PFs) was taken with confocal microscopy of which a part is shown here. (D) Low level
tox staining. (E) Cross-sectional overview of a 3-dimensional image using 12 z-stacks
ntiﬁcation of NETs by percentage area of Sytox green positive DNA in a 3D z-stack image,
L). Bars representmean±SEM. *pb 0.05. Results are representative for three experiments.
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Fig. 4.Quantiﬁcation of NET release induced by RA and SLE serum. (A) NET releasewasmeasured upon inductionwith 10% serum from 27 RA patients, 20 SLE patients and 6 NHS controls.
(B) The amount of NET release upon stimulation with RA and SLE serum is shown relative to the NHS control (fold induction). The NHS control value is based on three different NHS
samples used per experiment. The fold induction was calculated relative to the mean NHS value within the same experiment. All samples were tested in triplicate. NET release is
induced in 18 out of 27 RA samples and in 17 out of 20 SLE samples. Each sample is represented by one dot or cube.
583T. Kraaij et al. / Autoimmunity Reviews 15 (2016) 577–584that the current assay includes limited pipetting steps, since no anti-
body stainings are used. Taken together, this novel assay has a signiﬁ-
cantly increased yield of NET detection, due to an increased sensitivity
as compared to the currently reported assays to quantify NET release.
Quantifying NETs by immunoﬂuorescence microscopy is inherently
associated with observer subjectivity when images are acquired. To ad-
dress this issue,we automated image acquisitionwhichmade it possible
to capture 300HPFs (25HPFs in 12 z-stacks) for eachwell and, addition-
ally, eliminate observer subjectivity and inter-observer variability dur-
ing image acquisition. As a consequence, to handle the large image
data sets, we semi-automated the digital image analysis. Thus, in con-
trast to previous NET quantiﬁcation methods, we were able to identify
a major reduction in PKH staining upon stimulation with PMA. This is
most likely a result of general neutrophil death through NETosis in-
duced by PMA. Importantly, neutrophil cell loss by NETosis was much
smaller upon incubation with ICx illustrative of a quantitatively and
qualitatively different process compared to PMA. Collectively, automat-
ed image acquisition of large areas from each well increased sensitivity
while reducing observer subjectivity when quantifying NET release.
An important advantage of this assay is that it is compatible with the
use of human IgG immune complexes. Previous reports investigating
NET induction by ICx studied non-human ICx, such as soluble BSA/
rabbit anti-BSA ICx [21] or immobilized HSA/rabbit polyclonal anti-
HSA ICx [13]. Until now, it was a common problem to measure human
ICx-induced NET release in a Sytox green ﬂuorescence assay (data not
shown) or with Picogreen DNA measurements due to the interference
of human IgG with the detection method [18]. Another complication is
the lack of sensitivity of previous conventional methods. To our knowl-
edge, this is the ﬁrst assay using a fully humanized system for NET
quantiﬁcation with human ICx.
There are a few limitations to this assay. First of all, inter-assay var-
iability is present since the optimal imaging settings (e.g. exposure
time) and analysis settings (e.g. intensity threshold) can vary between
experiments. The use of different neutrophil donors is an uncontrollable
variable that could add to inter-assay variability. Another limitation is
the use of the speciﬁc dyes PKH26 and Sytox. Amore speciﬁc NETmark-
er could improve the assay's speciﬁcity for NETs. However, as yet, theFig. 3. High sensitivity quantiﬁcation of ICx-induced NET release is ROS-independent. (
diphenyleneiodonium (DPI) and subsequently NETs were induced with human IgG (6.25
inhibition did not inﬂuence ICx-induced NET release, plotted on the left y-axis, whereas PMA
not signiﬁcant, **p b 0.005. (B) Corresponding cross-sectional overview of a 3-dimensional im
are representative for three experiments. Bars represent mean ± SEM.current available NET-speciﬁc stainings such as citrullinated histone
and neutrophil elastase have a low sensitivity and would therefore re-
duce the current assay's sensitivity to detect low levels of extracellular
DNA [24,25]. Future investigations will attempt to further reduce
assay variability and decrease duration of image acquisition.
The applicability of this method was ﬁrst established in our experi-
ments characterizing human ICx-induced NET release. By using DPI,
which inhibits NADPH oxidase and ROS production, we demonstrated
that ICx induction of (low levels of) NET release was different from
PMA-induced (high levels of) NET release. This observation was in ac-
cordance with a previous report showing that soluble BSA/anti-BSA
ICx-induced NET release is independent on the formation of ROS [21].
Moreover, we show the ability of this assay to quantify NET release
upon stimulation with sera from RA and SLE patients. Compared to
the NHS control, RA and SLE sera show increased capability to induce
NET release. To minimize the potential inter-assay variability, the NET-
inducing capacity is shown relative to the NHS control used in the
corresponding experiment aswell in Fig. 4B. In summary, we could suc-
cessfully quantify the NET-inducing capacity of RA and SLE sera. Further
investigations will focus on the NET-inducing capacity of multiple AID
samples and factors involved in NET release in AID.
In conclusion, we have described a novel method to quantify NET
release in vitro by applying a semi-automated 3D CLSM image anal-
ysis. This assay has four advantages over the currently reported, con-
ventional methods for NET quantiﬁcation: 1) the assay has increased
sensitivity to detect low levels of NETs; 2) the assay is semi-
automated minimizing observer variability; 3) the assay is per-
formed in a fully humanized system; 4) the assay allows high-
throughput analysis. With this novel method we were able to detect
NET release induced by RA and SLE serum samples with high sensi-
tivity. Future investigations will aim to apply this assay in order to
investigate the ability of circulating factors to induce NET release in
autoantibody-mediated diseases, such as ANCA-associated vasculi-
tis, SLE, rheumatoid arthritis, antiphospholipid syndrome and
cryoglobulinemic vasculitis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.autrev.2016.02.018.A) NADPH-oxidase was inhibited through pre-incubation of neutrophils with 1 μM
μg/ml), ICx (6.25 μg/ml) and PMA (25 nM) or medium (unstimulated control). ROS-
-induced NET release, plotted on the right y-axis, was almost completely blocked. ns =
ages using 12 z-stacks illustrating ICx-induced NET release is ROS independent. Results
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• We developed a highly sensitive method for the detection and
quantiﬁcation of low level neutrophil extracellular trap (NET) re-
lease.
• This novel method was successfully applied for the quantiﬁcation
of the NET-inducing capacity of human immune complexes and
sera from rheumatoid arthritis and systemic lupus erythematosus
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